Open AccessEndometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy
Author(s) -
Alka Jindal,
Manjit Kaur Mohi,
Manjeet Kaur,
Balwinder Kaur,
Risham Singla,
Shaunik Singh
Publication year - 2015
Publication title -
journal of mid-life health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.423
H-Index - 11
eISSN - 0976-7819
pISSN - 0976-7800
DOI - 10.4103/0976-7800.158947
Subject(s) - medicine , tamoxifen , hysteroscopy , endometrial polyp , endometrium , carcinoma , breast cancer , endometrial cancer , gynecology , endometrial hyperplasia , incidence (geometry) , population , radiology , obstetrics , cancer , physics , environmental health , optics
Tamoxifen, a nonsteroidal antiestrogenic agent, is used widely as adjunctive therapy for women with breast cancer. Most studies have found that the increased relative risk of developing endometrial cancer for women taking Tamoxifen is two to three times higher than that of an age-matched population. So we designed this study to assess the endometrial status in patients taking Tamoxifen for breast carcinoma.